American International Group, Inc. Global Blood Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $48,405 - $101,860	1,494 Added 5.12%	30,664 $2.09 Million
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $35,345 - $59,263	-1,585 Reduced 5.15%	29,170 $932,000
Q1 2022 May 13, 2022	SELL	$25.68 - $35.59 $55,571 - $77,016	-2,164 Reduced 6.57%	30,755 $1.07 Million
Q4 2021 Feb 11, 2022	BUY	$24.9 - $40.26 $4,008 - $6,481	161 Added 0.49%	32,919 $964,000
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $19,823 - $29,050	-778 Reduced 2.32%	32,758 $835,000
Q2 2021 Aug 13, 2021	BUY	$32.46 - $43.42 $1.05 Million - $1.4 Million	32,205 Added 2419.61%	33,536 $1.17 Million
Q1 2021 May 07, 2021	SELL	$38.94 - $50.85 $6,191 - $8,085	-159 Reduced 10.67%	1,331 $54,000
Q4 2020 Feb 12, 2021	SELL	$37.65 - $63.77 $1,543 - $2,614	-41 Reduced 2.68%	1,490 $65,000
Q3 2020 Nov 04, 2020	SELL	$52.76 - $74.49 $3,693 - $5,214	-70 Reduced 4.37%	1,531 $84,000
Q2 2020 Aug 12, 2020	SELL	$48.73 - $81.82 $1.59 Million - $2.67 Million	-32,692 Reduced 95.33%	1,601 $101,000
Q1 2020 May 04, 2020	SELL	$41.72 - $87.2 $82,689 - $172,830	-1,982 Reduced 5.46%	34,293 $1.75 Million
Q4 2019 Feb 05, 2020	SELL	$45.7 - $81.86 $13,938 - $24,967	-305 Reduced 0.83%	36,275 $2.88 Million
Q3 2019 Nov 08, 2019	BUY	$45.35 - $57.91 $88,931 - $113,561	1,961 Added 5.66%	36,580 $1.78 Million
Q2 2019 Aug 13, 2019	BUY	$52.6 - $63.29 $25,195 - $30,315	479 Added 1.4%	34,619 $1.82 Million
Q1 2019 May 06, 2019	BUY	$39.99 - $53.48 $49,707 - $66,475	1,243 Added 3.78%	34,140 $1.81 Million
Q4 2018 Feb 13, 2019	SELL	$31.54 - $46.67 $7,948 - $11,760	-252 Reduced 0.76%	32,897 $1.35 Million
Q3 2018 Nov 09, 2018	BUY	$38.0 - $51.1 $22,724 - $30,557	598 Added 1.84%	33,149 $1.26 Million
Q2 2018 Aug 08, 2018	BUY	$38.7 - $50.15 $296,209 - $383,848	7,654 Added 30.74%	32,551 $1.47 Million
Q1 2018 May 07, 2018	BUY	$39.6 - $65.9 $1,108 - $1,845	28 Added 0.11%	24,897 $1.2 Million
Q4 2017 Feb 09, 2018	BUY	$29.7 - $45.7 $3,474 - $5,346	117 Added 0.47%	24,869 $979,000
Q3 2017 Nov 09, 2017	BUY	$25.1 - $31.05 $621,275 - $768,549	24,752	24,752 $769,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account